Benzinga | May 11, 2021 09:47AM EDT

Wedbush Maintains Outperform on Cerence, Lowers Price Target to $130

Wedbush analyst Daniel Ives maintains Cerence (NASDAQ:CRNC) with a Outperform and lowers the price target from $150 to $130.